查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046515

心肺壓力測試系統市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、最終用戶、地區和競爭對手分類，2021-2031年

Cardiopulmonary Stress Testing System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心肺壓力測試系統市場預計將從 2025 年的 53.1 億美元成長到 2031 年的 76.1 億美元，複合年成長率達到 6.18%。

這些診斷設備對於評估運動負荷下的心肺功能以及詳細測量氣體交換和心臟功能至關重要。該市場的成長主要受慢性心血管和呼吸系統疾病盛行率上升的驅動。這些疾病需要精確的生理評估以製定有效的治療方案。此外，隨著全球人口老化，頻繁監測心肺功能變得特別必要，從而維持了臨床實踐中對這些診斷方法的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 53.1億美元
市場規模：2031年 76.1億美元
複合年成長率：2026-2031年 6.18%
成長最快的細分市場 脈搏血氧飽和度分析儀
最大的市場 北美洲

市場促進因素

心肺運動試驗系統市場的發展主要受心血管疾病和慢性阻塞性肺病）盛行率不斷上升的驅動。隨著這些疾病的日益普遍，人們對精準的診斷工具的需求也日益成長，這些工具能夠評估患者的功能狀態並指導治療策略。臨床醫生越來越依賴運動試驗來檢測缺血、評估心臟衰竭的預後以及監測高風險患者群體的疾病進展。美國心臟協會（AHA）2025年1月發布的報告等數據也支持了這一趨勢，該報告估計約有48.6%的美國成年人患有某種形式的心血管疾病。同時，生活方式相關危險因子（尤其是肥胖和糖尿病）盛行率的上升進一步加速了市場滲透。心肺運動試驗（CPET）對於早期診斷干預、制定安全的運動方案以及降低代謝紊亂患者的長期健康風險至關重要。世界肥胖聯盟於 2025 年 3 月發布的研究報告強調了這項需求。報告指出，超重和肥胖每年導致約 160 萬人死於非傳染性疾病。

市場挑戰

心肺壓力測試系統市場擴張的主要障礙是其高昂的實施成本，這對小規模醫療機構和社區診所的影響尤其顯著。這些診斷設備需要大量的資本投入，對於預算有限的機構而言往往難以負擔。因此，許多醫療機構只能使用基礎的壓力測試，而無法獲得先進系統提供的全面氣體交換分析。這導致先進系統的應用主要集中在大型醫院，從而縮小了整體目標市場。這種經濟壓力與先進醫療技術應用率的下降直接相關。根據美國醫院協會 (AHA) 2025 年的一份報告，預計約 94% 的醫療機構管理者將推遲設備升級以應對財務負擔，這將延長資本密集型診斷設備的銷售週期，並成為行業成長的重大瓶頸。

市場趨勢

心肺壓力測試系統市場正受到兩大趨勢的重塑。首先，人工智慧 (AI) 的整合應用實現了自動化診斷解讀，使複雜的氣體交換分析標準化。 AI 演算法能夠辨識人類觀察常常忽略的細微生理模式，顯著縮短臨床醫師的學習曲線，即使在非專業環境下也能確保專家級的診斷準確性。美國心臟病學會 (ACC) 2025 年 3 月的報告強調了這一點，該報告顯示，用於風險分層的深度學習模型優於臨床醫生的解讀。其次，精英測試在運動醫學的應用正在顯著擴展，其關注點從精英運動員轉向了面向大眾的預防性健康維護。 KORR Medical Technologies 於 2025 年 2 月發布的一項分析證實，客觀的健身指標比體重指數 (BMI) 更能預測死亡率，在這項臨床證據的支持下，醫療機構正在加速將心肺運動試驗 (CPET) 作為評估心肺功能的主要健康指標。因此，旨在提供數據驅動的健康最佳化方案的私人健康中心正在逐步採用這種方法。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心肺壓力測試系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（脈搏血氧飽和度分析儀、運動血壓監測儀、動態心電圖）
    • 透過應用（術前評估、運動壓力測試）
    • 依最終使用者（醫院/診所、門診中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心肺壓力測試系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心肺壓力測試系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心肺壓力測試系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲心肺壓力測試系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲心肺壓力測試系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球心肺壓力測試系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Koninklijke Philips NV
  • Hillrom Services Inc.
  • General Electric Company
  • MGC Diagnostics Corporation.
  • OSI Systems Inc.
  • Schiller AG
  • NIHON KOHDEN CORPORATION
  • Vyaire Medical, Inc.
  • Halma plc
  • Cosmed srl

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17388

The global market for cardiopulmonary stress testing systems is projected to increase from USD 5.31 billion in 2025 to USD 7.61 billion by 2031, achieving a compound annual growth rate of 6.18%. These diagnostic instruments are essential for assessing heart and lung performance under physical exertion, meticulously measuring gas exchange and cardiac function. Growth in this market is primarily fueled by the escalating prevalence of chronic cardiovascular and respiratory diseases, which necessitates accurate physiological assessments for effective treatment planning. Additionally, the growing global geriatric population requires frequent monitoring of cardiopulmonary health, thereby sustaining demand for these diagnostic modalities in clinical settings.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.31 Billion
Market Size 2031USD 7.61 Billion
CAGR 2026-20316.18%
Fastest Growing SegmentPulse Oximeter
Largest MarketNorth America

Market Driver

The market for cardiopulmonary stress testing systems is significantly propelled by the increasing incidence of cardiovascular and chronic obstructive pulmonary diseases. As these conditions become more widespread, the demand for precise diagnostic tools to evaluate functional capacity and guide treatment strategies intensifies. Clinicians increasingly rely on stress tests for detecting ischemia, assessing heart failure prognosis, and monitoring disease progression in high-risk patient groups, a trend supported by reports such as the American Heart Association's January 2025 update, which estimated approximately 48.6% of U.S. adults live with some form of cardiovascular disease. Concurrently, the rising prevalence of lifestyle-related risk factors, particularly obesity and diabetes, further accelerates market adoption. Cardiopulmonary exercise testing (CPET) is crucial for early diagnostic intervention, prescribing safe exercise regimens, and mitigating long-term health risks in metabolically compromised individuals, a need underscored by the World Obesity Federation's March 2025 finding that overweight and obesity are responsible for about 1.6 million premature deaths annually from non-communicable diseases.

Market Challenge

A primary impediment to market expansion for cardiopulmonary stress testing systems is their high acquisition cost, particularly impacting smaller healthcare providers and community clinics. These diagnostic units necessitate substantial capital investment, often rendering them unaffordable for facilities with limited budgets. Consequently, many providers are constrained to utilizing basic stress tests, which lack the comprehensive gas exchange analysis offered by advanced systems, thereby concentrating advanced system adoption in larger hospitals and diminishing the overall addressable market. This economic pressure directly correlates with reduced procurement of advanced medical technologies, with the American Hospital Association reporting in 2025 that about 94% of healthcare administrators expected to defer equipment upgrades to manage financial strain, thus creating a significant bottleneck for industry growth by extending sales cycles for capital-intensive testing units.

Market Trends

The market for cardiopulmonary stress testing systems is being reshaped by two key trends. First, the integration of Artificial Intelligence for automated diagnostic interpretation is standardizing complex gas exchange analysis. AI algorithms can identify subtle physiological patterns often missed by human observation, significantly shortening the learning curve for clinicians and ensuring expert-level diagnostic accuracy in non-specialized settings, as highlighted by an ACC March 2025 report where a deep learning model for risk stratification outperformed clinician interpretation. Second, there's a notable expansion of metabolic testing applications in sports medicine, moving beyond elite athletics to focus on preventive wellness for the general population. Facilities are increasingly employing CPET to assess cardiorespiratory fitness as a primary health metric, driven by clinical validation such as KORR Medical Technologies' February 2025 analysis confirming that objective fitness measures are more predictive of mortality than body mass index, thus prompting procurement by commercial wellness centers aiming to offer data-driven health optimization programs.

Key Market Players

  • Koninklijke Philips NV
  • Hillrom Services Inc.
  • General Electric Company
  • MGC Diagnostics Corporation.
  • OSI Systems Inc.
  • Schiller AG
  • NIHON KOHDEN CORPORATION
  • Vyaire Medical, Inc.
  • Halma plc
  • Cosmed srl

Report Scope

In this report, the Global Cardiopulmonary Stress Testing System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiopulmonary Stress Testing System Market, By Product

  • Pulse Oximeter
  • Stress Blood Pressure Monitor
  • Stress ECG

Cardiopulmonary Stress Testing System Market, By Application

  • Preoperative Evaluation
  • Stress Testing In Sport

Cardiopulmonary Stress Testing System Market, By End user

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Cardiopulmonary Stress Testing System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiopulmonary Stress Testing System Market.

Available Customizations:

Global Cardiopulmonary Stress Testing System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiopulmonary Stress Testing System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Pulse Oximeter, Stress Blood Pressure Monitor, Stress ECG)
    • 5.2.2. By Application (Preoperative Evaluation, Stress Testing In Sport)
    • 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cardiopulmonary Stress Testing System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiopulmonary Stress Testing System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Cardiopulmonary Stress Testing System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Cardiopulmonary Stress Testing System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End user

7. Europe Cardiopulmonary Stress Testing System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiopulmonary Stress Testing System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End user
    • 7.3.2. France Cardiopulmonary Stress Testing System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Cardiopulmonary Stress Testing System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Cardiopulmonary Stress Testing System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Cardiopulmonary Stress Testing System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End user

8. Asia Pacific Cardiopulmonary Stress Testing System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiopulmonary Stress Testing System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End user
    • 8.3.2. India Cardiopulmonary Stress Testing System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Cardiopulmonary Stress Testing System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Cardiopulmonary Stress Testing System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Cardiopulmonary Stress Testing System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End user

9. Middle East & Africa Cardiopulmonary Stress Testing System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiopulmonary Stress Testing System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Cardiopulmonary Stress Testing System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Cardiopulmonary Stress Testing System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End user

10. South America Cardiopulmonary Stress Testing System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiopulmonary Stress Testing System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Cardiopulmonary Stress Testing System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Cardiopulmonary Stress Testing System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiopulmonary Stress Testing System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Koninklijke Philips NV
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hillrom Services Inc.
  • 15.3. General Electric Company
  • 15.4. MGC Diagnostics Corporation.
  • 15.5. OSI Systems Inc.
  • 15.6. Schiller AG
  • 15.7. NIHON KOHDEN CORPORATION
  • 15.8. Vyaire Medical, Inc.
  • 15.9. Halma plc
  • 15.10. Cosmed srl

16. Strategic Recommendations

17. About Us & Disclaimer